Compare ARK Genomic Revolution ETF (ARKG) vs Fox Corp Class A (FOXA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Fox Corp Class A — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Fox Corp Class A trades at $54.28 (market cap $21.54B). The key difference: Fox Corp Class A pays a 1.03% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Fox Corp Class A nearer its low. Which is the better fit depends on your goals.
| ARKG | FOXA | |
|---|---|---|
Sector | Sector/Thematic | Media |
52-Week High | $43.57 | $76.11 |
52-Week Low | $23.09 | $48.79 |
Market Cap | — | $21.54B |
Enterprise Value | — | $25.51B |
Dividend Yield | — | 1.03% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
FOXA trades at $54.12, up 0.71% today, with a bearish technical signal despite recent earnings beats. The company reported strong 2025 results with revenue of $16.3B and net income of $2.26B, but faces headwinds from its $22B Roku acquisition. Analyst consensus remains positive with a $67.80 price target, though technical indicators show selling pressure near resistance at $55.
The outlook balances solid fundamentals against acquisition integration risks. FOXA's attractive valuation (P/E 14.24) and cash flow strength support upside potential, but investor sentiment is cautious due to leverage from the Roku deal. Near-term performance hinges on successful execution of streaming strategy amid industry consolidation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Fox Corp Class A
Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.
Read more on FOXA →
